$STIM

Chernett Jorey purchased $62K of STIM

Chernett Jorey purchased 35,000 shares of Neuronetics, Inc. (STIM) at $1.78 on 2026-07-14.

Original reporting
SEC EDGAR · Chernett Jorey
Published Jul 15, 2026, 1:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 1:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STIM
Bullish
medium confidence
Mentioned
$STIM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STIMBullishLow
01

Why it matters

A 10% owner purchased 35,000 shares at $1.7800, totaling $62,300, with holdings after the trade of 10,588,988 shares.

02

Market read

Traders may view the buy as a modest sentiment input, but there is no new operational or financial information.

03

What to watch

The article does not state whether the purchase was part of a broader pattern, nor does it provide any 10b5-1 plan context (it says none), limiting inference about intent.

Relevance 4/10Novelty 3/10Timing: new Form 4 filed 2026-07-15, covering a 2026-07-14 purchase

Background

This is an SEC Form 4 insider transaction disclosure for Neuronetics, Inc. (STIM).

Company-level read

Ticker impact

$STIMBullishMedium confidence
Context

Neuronetics insider Chernett Jorey, a 10% owner, bought 35,000 shares at $1.7800 on 2026-07-14 via open-market purchase.

Expected impact

Likely limited near-term impact; may modestly support sentiment if traders treat it as a confidence signal.

Evidence & confidence

Form 4 insider buys can influence sentiment, but this article provides no accompanying guidance, operational update, or material corporate event.

Market effects

No sector-level read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity or diversification activity and may not reflect near-term business improvement.

Key entities

  • Neuronetics, Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Chernett Jorey

    10% owner who executed an open-market purchase.

Related articles

$STIMMed

Why Is Neuronetics Stock Soaring Monday? - Neuronetics (NASDAQ:STIM)

Neuronetics (STIM) shares rose more than 28% Monday after BTIG initiated coverage with a Buy rating and a $5 price forecast, based on 2.5 times estimated sales. The article links the move to Neuronetics’ 2024 Greenbrook TMS acquisition, adding TMS and Spravato. It cites Q1 results: loss of 16 cents and sales of $34.454M.